MedTrace Logo

Psychosocial Pain Management to Improve Opioid Use Disorder Treatment Outcomes

NCT04433975 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-07-09

Study results available
· View outcomes & findings →

Summary

The purpose of this research study is to look at the effect of programs aimed at helping people manage chronic pain and medication treatment. The program sessions focus on educational information and strategies for pain and medication management. The researchers enroll people who have chronic pain and have recently begun buprenorphine treatment to see if participants could benefit from these programs. This research study will help the researchers learn how to improve current therapies for pain and medication management.

Conditions

  • Opioid-use Disorder
  • Medication Assisted Treatment
  • Chronic Pain

Interventions

BEHAVIORAL

Psychosocial Pain Management (PPMI)

The main theme of the treatment is to provide participants with new ways of thinking and coping skills related to managing pain and opioid use in order to increase the likelihood the participant may remain in buprenorphine treatment.

BEHAVIORAL

Enhanced Usual Care (EUC)

The EUC condition is designed to match the PPMI condition in terms of the non-specific aspects of receiving support for pain, substance use, and receiving monitoring of buprenorphine adherence.

Sponsors & Collaborators

Principal Investigators

  • Allison Lin, M.D., M.S. · University of Michigan

  • Mark Ilgen, Ph.D. · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-14
Primary Completion
2024-05-23
Completion
2025-01-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04433975 on ClinicalTrials.gov